An Online Nurse-Led Purpose-Focused Group Program for Adult Women With Multiple Sclerosis: Effects on Meaning and Quality of Life
Part of paid clinical trials in Denton, Texas.
- Sponsor
- Texas Woman's University
- Study ID
- NCT07555015
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Nurse-Led Purpose-Building Intervention — BEHAVIORALThe Nurse-Led Virtual Purpose-Building Intervention is a six-week, synchronous behavioral program delivered in small groups through a secure videoconferencing platform. Sessions are facilitated by a registered nurse trained in the study protocol. Each weekly session lasts 60 minutes and follows a standardized structure that includes: (1) an opening reflective prompt or grounding exercise, (2) guided group dialogue focused on meaning, identity, and purpose in the context of living with Multiple Sclerosis, (3) a brief integrative activity such as journaling or values-based reflection, and (4) a closing synthesis. The intervention emphasizes person-centered exploration, reflective engagement, and meaning-making rather than clinical counseling or symptom management. No medical treatments, diagnostic procedures, or therapeutic techniques are used. Fidelity to session structure is supported through a facilitator manual and weekly documentation.
Study Details
The goal of this study is to learn how a six-week, nurse-led virtual group program may affect meaning in life and quality of life in adult women living with Multiple Sclerosis (MS). Many people with MS describe changes in identity, purpose, and daily life. This study will help researchers understand whether a structured group program can support women as they explore meaning and purpose while living with MS. The main questions this study aims to answer are: * How does the program affect how participants search for meaning in life? * How does it affect their sense of life purpose or direction? * How does it affect their overall quality of life? This study uses a single-group design. All participants will take part in the six-week virtual group program. The program is led by a registered nurse and focuses on guided reflection, values exploration, and group discussion. Participants will: * Attend one virtual group session for one hour each week for six weeks * Take part in guided discussions and reflection exercises * Complete three online surveys: one before the program begins, one at Week 3, and one after Week 6 * Use a computer, tablet, or phone to join all virtual sessions The surveys will ask about: * How participants search for meaning in their lives * How much purpose and direction they feel * Their physical and emotional quality of life There are no medications, invasive procedures, or in-person visits in this study.
Key Dates
- First listed
- Apr 28, 2026
- Start date
- Jul 31, 2026
- Status verified
- Apr 2026
- Primary completion
- Sep 30, 2026
- Completion
- Sep 30, 2026
Study Design
- Enrollment
- 40 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: Nurse-Led Virtual Purpose-Building Intervention
Primary Outcome Measure
Change in Quality of Life (Multiple Sclerosis Quality of Life-29 Scale) [ Time Frame: Baseline, Week 3, Week 6 ]
Central Contacts
- Lisa Kelly254-368-7638
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Texas Woman's University | Denton | Texas | 76204 |
Find similar trials in Denton, TX
Related Studies
- NARCOMS Registry: A Multiple Sclerosis RegistryRecruiting · University of Texas Southwestern Medical Center · Dallas, Texas
- Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVOPHASE1 · Recruiting · National Cancer Institute (NCI) · Sacramento, California
- Non-invasive BCI-controlled Assistive DevicesRecruiting · University of Texas at Austin · Austin, Texas
- Ocrelizumab Discontinuation in Relapsing Multiple SclerosisPHASE4 · Recruiting · National Institute of Allergy and Infectious Diseases (NIAID) · New Haven, Connecticut